Short bowel patients treated for two years with glucagon-like peptide 2: Effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function

Gastroenterology Research and Practice

Volumn , Issue , 2009, Pages

  Jeppesen, P B ^a   Lund, P ^a   Gottschalck, I B ^a   Nielsen, H B ^a   Holst, J J ^b   Mortensen, J ^a   Poulsen, S S ^b   Quistorff, B ^b   Mortensen, P B ^a  

^a Rigshospitalet   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CREATININE; GLUCAGON LIKE PEPTIDE 2; LOPERAMIDE; OMEPRAZOLE; OPIATE; OSTEOCALCIN; PARATHYROID HORMONE; TEDUGLUTIDE; VITAMIN D;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BODY COMPOSITION; BONE DENSITY; BONE TURNOVER; CALORIC INTAKE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENERGY ABSORPTION; EXERCISE TEST; EXPIRATORY RESERVE VOLUME; FECES ANALYSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INTESTINE ABSORPTION; INTESTINE FUNCTION; INTESTINE MUCOSA; KIDNEY FUNCTION; LUNG FUNCTION; MALE; MUSCLE FUNCTION; NUCLEAR MAGNETIC RESONANCE; PARENTERAL NUTRITION; SHORT BOWEL SYNDROME; TREATMENT DURATION; URINE VOLUME;

EID: 69249219020     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2009/616054     Document Type: Article

References (39)

1. Orskov C., Holst J. J., Knuhtsen S., Baldissera F. G., Poulsen S. S., Nielsen O. V., Glucagon-like peptides GLP-1 and GLP-2, predicted products of the glucagon gene, are secreted separately from pig small intestine but not pancreas Endocrinology 1986 119 4 1467 1475
2. Wojdemann M., Wettergren A., Hartmann B., Hilsted L., Holst J. J., Inhibition of sham feeding-stimulated human gastric acid secretion by glucagon-like peptide-2 Journal of Clinical Endocrinology and Metabolism 1999 84 7 2513 2517
3. Bozkurt A., Naslund E., Holst J. J., Hellstrom P. M., GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat Regulatory Peptides 2002 107 13 129 135
4. Wojdemann M., Wettergren A., Hartmann B., Holst J. J., Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs Scandinavian Journal of Gastroenterology 1998 33 828 832
5. Guan X., Stoll B., Lu X., GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets Gastroenterology 2003 125 1 136 147
6. Drucker D. J., Ehrlich P., Asa S. L., Brubaker P. L., Induction of intestinal epithelial proliferation by glucagon-like peptide 2 Proceedings of the National Academy of Sciences of the United States of America 1996 93 15 7911 7916
7. Drucker D. J., DeForest L., Brubaker P. L., Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2 American Journal of Physiology 1997 273 6 G1252 G1262
8. Litvak D. A., Hellmich M. R., Evers B. M., Banker N. A., Townsend C. M. Jr., Glucagon-like peptide 2 is a potent growth factor for small intestine and colon Journal of Gastrointestinal Surgery 1998 2 2 146 150
9. Orskov C., Hartmann B., Poulsen S. S., Thulesen J., Hare K. J., Holst J. J., GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors Regulatory Peptides 2005 124 13 105 112
10. Brubaker P. L., Izzo A., Hill M., Drucker D. J., Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2 American Journal of Physiology 1997 272 6 E1050 E1058
11. Cheeseman C. I., ONeill D., Basolateral D-glucose transport activity along the crypt-villus axis in rat jejunum and upregulation induced by gastric inhibitory peptide and glucagon-like peptide-2 Experimental Physiology 1998 83 5 605 616
12. Cheeseman C. I., Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP- 2 infusion in vivo American Journal of Physiology 1997 273 6 R1965 R1971
13. Henriksen D. B., Alexandersen P., Hartmann B., Disassociation of bone resorption and formation by GLP-2. A 14-day study in healthy postmenopausal women Bone 2007 40 3 723 729
14. Pironi L., Zolezzi C., Ruggeri E., Paganelli F., Pizzoferrato A., Miglioli M., Bone turnover in short-term and long-term home parenteral nutrition for benign disease Nutrition 2000 16 4 272 277
15. Jeppesen P. B., Hartmann B., Thulesen J., Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon Gastroenterology 2001 120 4 806 815
16. Jeppesen P. B., Sanguinetti E. L., Buchman A., Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant qlucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients Gut 2005 54 9 1224 1231
17. Haderslev K. V., Jeppesen P. B., Hartmann B., Short-term administration of glucagon-like peptide-2. Effects on bone mineral density and markers of bone turnover in short-bowel patients with no colon Scandinavian Journal of Gastroenterology 2002 37 4 392 398
18. Schmassmann A., Fehr H. F., Locher J., Cholylsarcosine, a new bile acid analogue: metabolism and effect on biliary secretion in humans Gastroenterology 1993 104 4 1171 1181
19. Schmassmann A., Angellotti M. A., Ton-Nu H. T., Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation Gastroenterology 1990 98 1 163 174
20. Heydorn S., Jeppesen P. B., Mortensen P. B., Bile acid replacement therapy with cholylsarcosine for short-bowel syndrome Scandinavian Journal of Gastroenterology 1999 34 8 818 823
21. Jeppesen P. B., Mortensen P. B., Colonic digestion and absorption of energy from carbohydrates and medium-chain fat in small bowel failure Journal of Parenteral and Enteral Nutrition 1999 23 5, supplement S101 S105
22. Jeppesen P. B., Staun M., Tjellesen L., Mortensen P. B., Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection Gut 1998 43 6 763 769
23. Rosenquist C., Fledelius C., Christgau S., Serum CrossLaps One Step ELISA. First application of monoclonal antibodies for measurement in serum of bone-related degradation products from C-terminal telopeptides of type I collagen Clinical Chemistry 1998 44 11 2281 2289
24. Cotes J. E., Chinn D. J., Quanjer P. H., Roca J., Yernault J. C., Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society The European Respiratory Journal 1993 16 41 52
25. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C., Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society The European Respiratory Journal 1993 16 5 40
26. Black L. F., Hyatt R. E., Maximal respiratory pressures: normal values and relationship to age and sex American Review of Respiratory Disease 1969 99 5 696 702
27. Ratkevicius A., Quistorff B., Metabolic costs of force generation for constant-frequency and catchlike-inducing electrical stimulation in human tibialis anterior muscle Muscle and Nerve 2002 25 3 419 426
28. Johansen L., Quistorff B., 31P-MRS characterization of sprint and endurance trained athletes International Journal of Sports Medicine 2003 24 3 183 189
29. Nakagawa Y., Ratkevicius A., Mizuno M., Quistorff B., ATP economy of force maintenance in human tibialis anterior muscle Medicine and Science in Sports and Exercise 2005 37 6 937 943
30. Galbo H., Kjaer M., Secher N. H., Cardiovascular, ventilatory and catecholamine responses to maximal dynamic exercise in partially curarized man Journal of Physiology 1987 389 557 568
31. Bogert L. W. J., van Lieshout J. J., Non-invasive pulsatile arterial pressure and stroke volume changes from the human finger Experimental Physiology 2005 90 4 437 446
32. Jeppesen P. B., Lund P., Gottschalck I. B., Short bowel patients treated for two years with Glucagon-Like Peptide 2 (GLP-2): compliance, safety and effects on quality of life Gastroenterology Research and Practice 2009 2009
33. Mizuno M., Horn A., Secher N. H., Quistorff B., Exercise-induced 31P-NMR metabolic response of human wrist flexor muscles during partial neuromuscular blockade American Journal of Physiology 1994 267 2, part 2 R408 R414
34. Friedman H. I., Chandler J. G., Peck C. C., Nemeth T. J., Odum S. K., Alterations in intestinal structure, fat absorption and body weight after intestinal bypass for morbid obesity Surgery Gynecology and Obstetrics 1978 146 5 757 767
35. Gleeson M. H., Bloom S. R., Polak J. M., Henry K., Dowling R. H., Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function Gut 1971 12 10 773 782
36. Stevens F. M., Flanagan R. W., OGorman D., Buchanan K. D., Glucagonoma syndrome demonstrating giant duodenal villi Gut 1984 25 7 784 791
37. Thulesen J., Hartmann B., Hare K. J., Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice Gut 2004 53 8 1145 1150
38. Sylvan A., Sjolund B., Janunger K. G., Rutegard J., Stenling R., Roos G., Colorectal cancer risk after jejunoileal bypass: dysplasia and DNA content in longtime follow-up of patients operated on for morbid obesity Diseases of the Colon and Rectum 1992 35 3 245 248
39. Lauverjat M., Aissa A. H., Vanhems P., Bouletreau P., Fouque D., Chambrier C., Chronic dehydration may impair renal function in patients with chronic intestinal failure on long-term parenteral nutrition Clinical Nutrition 2006 25 1 75 81